KR830005871A - 광견병 백신의 제조방법 - Google Patents
광견병 백신의 제조방법 Download PDFInfo
- Publication number
- KR830005871A KR830005871A KR1019810002356A KR810002356A KR830005871A KR 830005871 A KR830005871 A KR 830005871A KR 1019810002356 A KR1019810002356 A KR 1019810002356A KR 810002356 A KR810002356 A KR 810002356A KR 830005871 A KR830005871 A KR 830005871A
- Authority
- KR
- South Korea
- Prior art keywords
- virus
- inactivated
- rabies
- adjuvants
- carriers
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims 3
- 229960003127 rabies vaccine Drugs 0.000 title claims 2
- 241000700605 Viruses Species 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000000969 carrier Substances 0.000 claims 2
- 238000004113 cell culture Methods 0.000 claims 2
- 230000000415 inactivating effect Effects 0.000 claims 2
- 230000002381 testicular Effects 0.000 claims 2
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 241000711798 Rabies lyssavirus Species 0.000 claims 1
- 229940124861 Rabies virus vaccine Drugs 0.000 claims 1
- 241000282898 Sus scrofa Species 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 230000002779 inactivation Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 230000001902 propagating effect Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/819—Viral vaccine for feline species, e.g. cats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (2)
- 불활성화전 돼지 고환 세포 배양물중에서 성장시키기에 적합한 광견병 바이러스의 불활성화된 CHPSAD균주, 보조제 및 담체를 함유하는, 심각한 부작용없이 개 및 고양이와 동물에서 면역을 유도시킬 수 있는 불활성화 광견병 바이러스백신.
- 돼지 고환 세포 배양물중에서 관경병 바이러스의 HCP-SAD균주를 증식시키고 이 바이러스를 바이러스입자 또는 항원생성을 파괴하지 않는 불활성화제로 불활성화시키고 불활성화된 바이러스를 보조제 및 담체와 복합시킴을 특징으로 하여 특허 청구범위 1의 불활성화 광견병 백신을 제조하는 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US174306 | 1980-07-30 | ||
US06/174,306 US4347239A (en) | 1980-07-30 | 1980-07-30 | Inactivated rabies vaccine for veterinary use |
Publications (2)
Publication Number | Publication Date |
---|---|
KR830005871A true KR830005871A (ko) | 1983-09-14 |
KR840001514B1 KR840001514B1 (ko) | 1984-09-29 |
Family
ID=22635689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019810002356A KR840001514B1 (ko) | 1980-07-30 | 1981-06-30 | 광견병 백신의 제조방법 |
Country Status (14)
Country | Link |
---|---|
US (1) | US4347239A (ko) |
EP (1) | EP0044920B1 (ko) |
JP (1) | JPS5732227A (ko) |
KR (1) | KR840001514B1 (ko) |
AU (1) | AU544338B2 (ko) |
CA (1) | CA1183452A (ko) |
DE (1) | DE3160560D1 (ko) |
ES (1) | ES500199A0 (ko) |
HK (1) | HK50184A (ko) |
IE (1) | IE50889B1 (ko) |
NZ (1) | NZ196214A (ko) |
PH (3) | PH17383A (ko) |
SG (1) | SG3384G (ko) |
ZA (1) | ZA811042B (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4664912A (en) * | 1984-10-01 | 1987-05-12 | Wiktor Tadeusz J | Process for the large scale production of rabies vaccine |
DE3526809A1 (de) * | 1985-07-26 | 1987-04-02 | Behringwerke Ag | Tollwut-lebendimpfstoff |
EP0222974B1 (de) * | 1985-11-22 | 1991-11-13 | Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten | Verfahren zur Herstellung eines Tollwutimpfstoffes und nach diesem Verfahren erhaltener Impfstoff |
US4990367A (en) * | 1987-03-09 | 1991-02-05 | Diamond Scientific Company | Canine distemper virus vaccine |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
CN101846683B (zh) * | 2010-06-22 | 2014-08-06 | 普莱柯生物工程股份有限公司 | 一种猪瘟活疫苗效力检验方法 |
RU2537183C2 (ru) * | 2012-12-17 | 2014-12-27 | Открытое Акционерное Общество "Институт Биотехнологий Ветеринарной Медицины" | Способ получения инактивированной антирабической вакцины при безопорном выращивании клеток и репродукции в них вируса в укороченном цикле культивирования |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1030516B (de) * | 1957-03-14 | 1958-05-22 | Dr Med Gustav Seiffert | Naehrboden zur Viruszuechtung |
US3155589A (en) * | 1958-04-14 | 1964-11-03 | Upjohn Co | Parenteral extravascular injectable vaccines for simultaneous immunization of canidae against rabies, canine distemper, and infectious canine hepatitis |
US3397267A (en) * | 1964-09-21 | 1968-08-13 | Research Corp | Method of producing rabies vaccine |
US3423505A (en) * | 1964-10-31 | 1969-01-21 | Univ Toronto | Rabies vaccine and process for preparation thereof |
US3585266A (en) * | 1969-02-24 | 1971-06-15 | Dow Chemical Co | Live rabies virus vaccine and method for the production thereof |
US3769415A (en) * | 1969-06-04 | 1973-10-30 | Connaught Labor Ltd | Method of preparing a killed vaccine for oral use |
DE2162013C3 (de) | 1971-12-14 | 1981-10-15 | Johnson & Johnson, 08903 New Brunswick, N.J. | Tollwut-Lebendimpfstoff, Verfahren zu seiner Herstellung nd seine Verwendung bei der Bekämpfung von Tollwut |
FR2261779A1 (en) | 1974-02-26 | 1975-09-19 | Pasteur Institut | Anti-rabies vaccine - obtd. from rabies virus grown on foetal calf kidney cells in a synthetic serum-free medium |
FR2290220A2 (fr) | 1974-11-05 | 1976-06-04 | Pasteur Institut | Nouveau vaccin antirabique |
US4040904A (en) * | 1975-07-21 | 1977-08-09 | Slater Eban A | Novel rabies virus vaccine and processes |
DE2616407C3 (de) * | 1976-04-14 | 1980-02-21 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines Tollwut-Impfstoffs |
US4070453A (en) * | 1976-06-25 | 1978-01-24 | Syntex (U.S.A.) Inc. | Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines |
GB1596653A (en) | 1977-01-26 | 1981-08-26 | Gist Brocades Nv | Vaccine |
BE859178A (fr) | 1977-09-29 | 1978-01-16 | Cutter Lab | Souche de cellules et culture de virus |
-
1980
- 1980-07-30 US US06/174,306 patent/US4347239A/en not_active Expired - Lifetime
-
1981
- 1981-02-09 NZ NZ196214A patent/NZ196214A/en unknown
- 1981-02-09 IE IE240/81A patent/IE50889B1/en not_active IP Right Cessation
- 1981-02-10 AU AU67143/81A patent/AU544338B2/en not_active Expired
- 1981-02-13 PH PH25224A patent/PH17383A/en unknown
- 1981-02-17 ZA ZA00811042A patent/ZA811042B/xx unknown
- 1981-02-19 JP JP2416581A patent/JPS5732227A/ja active Granted
- 1981-02-20 CA CA000371357A patent/CA1183452A/en not_active Expired
- 1981-03-09 ES ES500199A patent/ES500199A0/es active Granted
- 1981-06-04 DE DE8181104298T patent/DE3160560D1/de not_active Expired
- 1981-06-04 EP EP81104298A patent/EP0044920B1/en not_active Expired
- 1981-06-30 KR KR1019810002356A patent/KR840001514B1/ko active
-
1983
- 1983-08-19 PH PH29417A patent/PH18743A/en unknown
-
1984
- 1984-01-13 SG SG33/84A patent/SG3384G/en unknown
- 1984-06-21 HK HK501/84A patent/HK50184A/xx not_active IP Right Cessation
-
1985
- 1985-01-18 PH PH31737A patent/PH22308A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPH0555487B2 (ko) | 1993-08-17 |
EP0044920A2 (en) | 1982-02-03 |
ES8202357A1 (es) | 1982-01-16 |
KR840001514B1 (ko) | 1984-09-29 |
DE3160560D1 (en) | 1983-08-11 |
IE810240L (en) | 1982-01-30 |
EP0044920A3 (en) | 1982-02-17 |
NZ196214A (en) | 1984-07-31 |
CA1183452A (en) | 1985-03-05 |
AU544338B2 (en) | 1985-05-23 |
US4347239A (en) | 1982-08-31 |
PH17383A (en) | 1984-08-06 |
ZA811042B (en) | 1982-05-26 |
ES500199A0 (es) | 1982-01-16 |
AU6714381A (en) | 1982-02-04 |
HK50184A (en) | 1984-06-29 |
IE50889B1 (en) | 1986-08-06 |
SG3384G (en) | 1985-02-01 |
EP0044920B1 (en) | 1983-07-06 |
PH18743A (en) | 1985-09-16 |
JPS5732227A (en) | 1982-02-20 |
PH22308A (en) | 1988-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900001382A (ko) | 연속 셀라인에서의 ibdv생성 | |
DE3486495D1 (de) | Hundecoronavirus | |
ATE103331T1 (de) | Vakzine. | |
SE7908516L (sv) | Sett att framstella ett bakteriostatiskt material | |
KR830005871A (ko) | 광견병 백신의 제조방법 | |
ATE19591T1 (de) | Virus der infektioesen katzen-bauchfellentzuendung, seine herstellung und es enthaltende vakzine. | |
ES2067921T3 (es) | Una biomasa y un procedimiento para la produccion de virus/antigeno de virus. | |
SE7512828L (sv) | Calicivirusvaccin | |
ATE43500T1 (de) | Herstellung von antikoerpern. | |
SE8105079L (sv) | Antibiotikum bmg162-af2 | |
ZA796476B (en) | Feline infectious peritonitis vaccine | |
DE3686158D1 (de) | Impfstoff gegen mastitis. | |
BR7707811A (pt) | Processo para desinfetar um sistema aquoso ou outro material contaminado com bacterias e/ou fungos | |
ATE95973T1 (de) | Pflanzenzuechtung. | |
ATE83929T1 (de) | Schweinenierenzellkultur und ihre verwendung fuer die herstellung von vakzinen. | |
KR900017611A (ko) | 개의 코로나 바이러스 백신 | |
IL67818A (en) | Vaccines comprising ozone inactivated viruses and their production | |
FR2108935A1 (en) | Sterile,diluted seawater - specific isotonic solns for treating haemorrhage,shock,diarrhoea in man and animals | |
FR2150799A1 (en) | Equine infectious anaemia - prepn of immunising vaccine | |
KR840008644A (ko) | 원예재배용 클로레라 비료의 제조방법 | |
GB1105179A (en) | Improvements in or relating to propagating human hepatitis virus | |
GB839876A (en) | A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus | |
KR850000909A (ko) | 활엽수 톱밥을 이용한 표고버섯 재배법 | |
SU1692146A1 (ru) | Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o | |
KR910001033A (ko) | 유전공학적으로 변형된 동물세포에서 생산된 B형 간염 표면항원(HBsAg)의 정제방법 |